Edition:
United Kingdom

People: Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

116.20USD
21 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$116.20
Open
$116.31
Day's High
$121.60
Day's Low
$115.28
Volume
104,103
Avg. Vol
73,314
52-wk High
$133.61
52-wk Low
$53.29

Smith, Scott 

Mr. Scott T. Smith has been Chief Financial Officer and Senior Vice President of Ascendis Pharma A/S since August 8, 2016. He most recently served as Director of the Healthcare Investment Banking Group at Wedbush Securities, from 2012 to 2016, where he led the healthcare team and oversaw a substantial increase in revenue and transaction volume. From 2009 to 2012, Mr. Smith served as a Managing Director at Wedbush. Prior to joining Wedbush, Mr. Smith served as a Director in the Global Healthcare Investment Banking Group at Merrill Lynch where he began his career in 1995. He has also worked in sales, marketing and strategy roles for various companies, including start-ups and a Fortune Global 500 company. Mr. Smith received his MBA from the Stanford University Graduate School of Business and graduated magna cum laude with a BA in Economics/Accounting - Physics from Claremont McKenna College.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --